BiotechTube
Home/DepYmed/Peter Van Ess, PharmD, PhD
PV

Peter Van Ess, PharmD, PhD

Senior Vice President of Early Development

DepYmed

Therapeutic Areas

Rett SyndromeOncologyWilson DiseaseMetabolic DiseasesNeurodegenerative Diseases

DepYmed Pipeline

DrugIndicationPhase
DPM-1003Rett SyndromePhase 1
PTP1B InhibitorOncologyPre-clinical
Copper ChelatorWilson DiseasePre-clinical

Leadership Team at DepYmed

AG
Andreas Grill
President & CEO
NT
Nicholas Tonks, PhD
Co-Founder & Research Advisor
View full DepYmed profile